News

Keep up with the latest news from the NCI Center for Biomedical Informatics and Information Technology (CBIIT) and the data science communities.

On November 30, 2020, the Food and Drug Administration’s precisionFDA will launch the COVID-19 Precision Immunology App-a-thon. Participants will develop applications and pipelines to illuminate the relationship between personalized, adaptive immunity molecular data and COVID-19 disease variables. The submission period is from November 30, 2020 to January 29, 2021.

NCI’s Proteomic Data Commons (PDC) has released new data from the Clinical Proteomic Tumor Analysis Consortium (CPTAC) and supplemental data from the Children’s Brain Tumor Network (CBTN). This release contains 350 gigabytes of open-access proteomic data, including breast, ovarian, and pediatric brain cancer studies.

NIH has released the updated Data Management and Sharing Policy. All NCI grantees will be required to submit a data sharing plan regardless of their funding level or mechanism. The policy will go into effect beginning January 25, 2023.

The NCI Imaging Data Commons (IDC) is now available. As the latest data repository within the NCI Cancer Research Data Commons, the IDC provides cloud-based access to medical imaging data and a library of analytical tools and workflows.

The NCI’s Childhood Cancer Data Initiative (CCDI) has released a new video about the initiative's vision of building a community around childhood cancer and research data. Featured in the video are advocates such as Amanda Haddock, president and co-founder of Dragon Master Foundation, and pediatric cancer researchers like Dr. Ned Sharpless, NCI Director, and Dr. Sam Volchenboum, Director of the Pediatric Cancer Data Commons. This video shares the importance of CCDI and its aspirations to improve outcomes for children and adolescents and young adults (AYAs) with cancer.

Ms. Smita Hastak, M.S., a senior analyst supporting NCI CBIIT, has been elected co-chair of Biomedical Research & Regulation at Health Level Seven International (HL7), an organization that provides standards for the exchange of health information and data.

The NCI R50 Award encourages the development of stable research career opportunities for exceptional scientists who want to pursue research within the context of an existing cancer research program, but not serve as independent investigators.

A new Funding Opportunity Announcement (FOA), “Genomic Data Analysis Network: Genomic Data Analysis Center (U24 Clinical Trial Not Allowed),” is soliciting applications for highly collaborative Genome Data Analysis Centers that will form the Genomic Data Analysis Network. Applications are due Thursday, November 12, 2020, at 5:00 p.m. ET.

The NCI's Cancer Research Data Commons' Proteomic Data Commons (PDC) has new data from the Clinical Proteomic Tumor Analysis Consortium’s lung squamous cell carcinoma and uterine corpus endometrial carcinoma studies.

NCI is launching the Cancer Moonshot℠ Seminar Series on September 24, 2020. The series will showcase the research progress from different Cancer Moonshot initiatives that support the 10 recommendations of the Blue Ribbon Panel report, including data sharing.